Table 1 Baseline characteristics of participants
From: A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
Characteristics | N = 15 |
|---|---|
Median age (range, years) | 51.3 (27–71) |
Age group, years, n (%) | |
49 and Under | 7 (46.7) |
50 to 59 | 4 (26.7) |
60 and Above | 4 (26.7) |
Gender n (%) | |
Male | 5 (33.3) |
Female | 10 (66.7) |
ECOG performance status n (%) | |
0 | 3 (20) |
1 | 12 (80) |
Tumor type, n (%) | |
Esophageal cancer | 1 (6.7) |
Gastric cancer | 2 (13.3) |
Colon cancer | 5 (33.3) |
Rectum cancer | 2 (13.3) |
Breast cancer | 3 (20.0) |
Soft tissue sarcoma | 2 (13.3) |